InspireMD (NSPR) Net Equity Issued and Repurchased (2011 - 2025)

InspireMD's Net Equity Issued and Repurchased history runs 12 years deep, the most recent figure standing at $38.0 million for Q3 2025.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $38.0 million in Q3 2025; TTM through Sep 2025 was $55.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $16.9 million, down 55.1% from the prior year.
• Net Equity Issued and Repurchased grew to $38.0 million in Q3 2025 per NSPR's latest filing, from $190000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $38.0 million in Q3 2025 and bottomed at -$35000.0 in Q3 2021.
• The 3-year median for Net Equity Issued and Repurchased is $506000.0 (2025), against an average of $12.9 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 138.89% in 2021; the steepest drop was 138.89% in 2021.
• Year by year, Net Equity Issued and Repurchased stood at -$35000.0 in 2021, then soared by 48154.29% to $16.8 million in 2024, then surged by 126.04% to $38.0 million in 2025.
• Per Business Quant, the three latest NSPR Net Equity Issued and Repurchased figures stand at $38.0 million (Q3 2025), $190000.0 (Q2 2025), and $506000.0 (Q1 2025).